The booming cell and gene therapy market is projected to reach $150 billion by 2033, driven by advancements in gene editing and the growing need for treatments for cancer, rare diseases, and other chronic illnesses. This in-depth analysis explores market size, growth drivers, trends, and key players, including Novartis, Amgen, and Pfizer.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.